{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:39:05Z","timestamp":1793104745465,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011676","name":"Elekta AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021692","name":"LabEx PRIMES","doi-asserted-by":"publisher","award":["ANR-11-LABX-0063"],"award-info":[{"award-number":["ANR-11-LABX-0063"]}],"id":[{"id":"10.13039\/501100021692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phro.2026.101097","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:58:41Z","timestamp":1790870321000},"page":"101097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["3D analysis and evolution of prostate and tumor oxygenation using MRI-derived relative oxygen extraction fraction during MR-guided stereotactic body radiotherapy"],"prefix":"10.1016","volume":"41","author":[{"given":"Thomas","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla","family":"Zidane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder","family":"Aloraibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Cervenansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Leporq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Beuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Henry","family":"Nailon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chapet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2026.101097_bb0005","author":"Global Cancer Observatory"},{"key":"10.1016\/j.phro.2026.101097_bb0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101097_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2021.09.026","article-title":"50 years of radiotherapy research: evolution, trends and lessons for the future","volume":"165","author":"Berger","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ijrobp.2023.05.004","article-title":"Toxicity and patient-reported quality-of-life outcomes after prostate stereotactic body radiation therapy with focal boost to magnetic resonance imaging-identified prostate cancer lesions: results of a phase 2 trial","volume":"117","author":"Morris","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101097_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.phro.2026.101097_bb0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2024.09.009","article-title":"Stereotactic radiation therapy for localized prostate cancer: 10-year outcomes from three prospective trials","volume":"121","author":"Kennedy","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101097_bb0035","article-title":"The carbon footprint of external beam radiotherapy and its impact in health technology assessment","volume":"48","author":"Dupraz","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0040","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57","author":"Horsman","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.phro.2026.101097_bb0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0055","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/1078-0432.CCR-11-2711","article-title":"Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer","volume":"18","author":"Milosevic","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phro.2026.101097_bb0060","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1016\/j.ijrobp.2011.05.037","article-title":"Hypoxic prostate\/muscle Po 2 ratio predicts for outcome in patients with localized prostate cancer: long-term results","volume":"82","author":"Turaka","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101097_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2018.12.022","article-title":"Reoxygenation during radiotherapy in intermediate-risk prostate cancer","volume":"133","author":"Supiot","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0070","doi-asserted-by":"crossref","first-page":"R323","DOI":"10.1088\/0031-9155\/60\/22\/R323","article-title":"Radiotherapy planning using MRI","volume":"60","author":"Schmidt","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2026.101097_bb0075","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jmri.26271","article-title":"Emerging role of MRI in radiation therapy","volume":"48","author":"Chandarana","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.phro.2026.101097_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep35142","article-title":"Multiparametric MRI-based differentiation of WHO grade II\/III glioma and WHO grade IV glioblastoma","volume":"6","author":"Wiestler","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.phro.2026.101097_bb0085","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00234-020-02585-8","article-title":"Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas","volume":"63","author":"Oughourlian","year":"2021","journal-title":"Neuroradiology"},{"key":"10.1016\/j.phro.2026.101097_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1754-9485.13626","article-title":"Towards tumour hypoxia imaging: incorporating relative oxygen extraction fraction mapping of prostate with multi-parametric quantitative MRI on a 1.5T MR-linac","volume":"68","author":"Mesny","year":"2024","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mri.2024.02.008","article-title":"Intravoxel incoherent motion magnetic resonance imaging to assess early tumor response to radiation therapy: review and future directions","volume":"108","author":"Mesny","year":"2024","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.phro.2026.101097_bb0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.168.2.3393671","article-title":"Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging","volume":"168","author":"Le Bihan","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/j.phro.2026.101097_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.705964","article-title":"Daily intravoxel incoherent motion (IVIM) in prostate Cancer patients during MR-guided radiotherapy\u2014a multicenter study","volume":"11","author":"Kooreman","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/nbm.3175","article-title":"Quantification of the triglyceride fatty acid composition with 3.0T MRI","volume":"27","author":"Leporq","year":"2014","journal-title":"NMR Biomed"},{"key":"10.1016\/j.phro.2026.101097_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mrm.10355","article-title":"Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7 Tesla","volume":"49","author":"Silvennoinen","year":"2003","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.phro.2026.101097_bb0120","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1007\/s10278-024-01110-0","article-title":"Development of a secure web-based medical imaging analysis platform: the AWESOMME project","volume":"37","author":"Diot-Dejonghe","year":"2024","journal-title":"J Imaging Inform Med"},{"key":"10.1016\/j.phro.2026.101097_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109491","article-title":"Visualization of tumor hypoxia and re-oxygenation after stereotactic body radiation therapy in early peripheral lung cancer: a prospective study","volume":"180","author":"Inada","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101097_bb0130","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00259-016-3431-4","article-title":"The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy","volume":"43","author":"Okamoto","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:27:34Z","timestamp":1793104054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631626001971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S2405631626001971"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2026.101097","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D analysis and evolution of prostate and tumor oxygenation using MRI-derived relative oxygen extraction fraction during MR-guided stereotactic body radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2026.101097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101097"}}